ELMD (Electromed) Total Equity: $49.17 Mil (As of Mar. 2026)


ELMD Electromed Inc ELMD
91 GF Score
Price $41.46
GF Value $25.16
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Electromed Total Equity?

Electromed ELMD +3.52% 91 Total Equity is $49.17 Mil as of Mar. 2026. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.16 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Electromed's total equity for the quarter that ended in Mar. 2026 was $49.17 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Electromed Total Equity Historical Data

* Premium members only.

The historical data trend for Electromed's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromed Total Equity Chart

Electromed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.42 34.17 37.67 44.55 43.21

Electromed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.94 43.21 44.75 45.44 49.17
ELMD
91GF Score
Electromed Inc ELMD
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Electromed Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Electromed's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=53.802-10.593
=43.21

Electromed's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=59.474-10.307
=49.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $49.17 Mil mean?
Electromed (ELMD) has a Total Equity of $49.17 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Electromed and its competitors.
Is Electromed's Total Equity too high?
Electromed's current Total Equity is $49.17 Mil. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Total Equity compare to MASS and SI?
Electromed's Total Equity of $49.17 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Electromed and its competitors. Electromed's current Total Equity is $49.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.16, compared to a current price of $41.46 — trading 64.8% above its estimated fair value. The current Total Equity is $49.17 Mil. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Electromed (ELMD), the current Total Equity is $49.17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Electromed (ELMD) Overvalued in 2026?

Based on GuruFocus' analysis, Electromed stock appears to be overvalued. The current stock price of $41.46 is trading 64.8% above its estimated GF Value™ of $25.16. GuruFocus considers Electromed to be Significantly Overvalued.

Key valuation signals for ELMD:

  • Total Equity: $49.17 Mil
  • GF Value™: $25.16 vs. price of $41.46 (64.8% above fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Electromed Business Description

Address 500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score

Get the complete analysis for ELMD

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.46
Price
$25.16
GF Value